Next Article in Journal
PUFAs and Their Derivatives as Emerging Players in Diagnostics and Treatment of Male Fertility Disorders
Previous Article in Journal
Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(5), 722; https://doi.org/10.3390/ph16050722
Action Date Notes Link
article pdf uploaded. 9 May 2023 16:27 CEST Version of Record https://www.mdpi.com/1424-8247/16/5/722/pdf-vor
article supplementary file uploaded. 9 May 2023 16:27 CEST - https://www.mdpi.com/1424-8247/16/5/722#supplementary
article xml uploaded. 10 May 2023 11:22 CEST Original file https://www.mdpi.com/1424-8247/16/5/722/xml
article pdf uploaded. 10 May 2023 11:22 CEST Updated version of record https://www.mdpi.com/1424-8247/16/5/722/pdf
article html file updated 10 May 2023 11:23 CEST Original file -
article supplementary file uploaded. 10 May 2023 11:28 CEST - https://www.mdpi.com/1424-8247/16/5/722#supplementary
article html file updated 10 May 2023 11:29 CEST Update https://www.mdpi.com/1424-8247/16/5/722/html
Back to TopTop